-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QGTC2pxKy3Tl+nVuaJJ0RqAlVo6ktmX5dE+XpW16yf76kOg492C7HKGD2sbVvYnJ b2YkQT0XdSy9589/iyHMDA== 0000936392-02-001331.txt : 20021105 0000936392-02-001331.hdr.sgml : 20021105 20021105124127 ACCESSION NUMBER: 0000936392-02-001331 CONFORMED SUBMISSION TYPE: 10-Q/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20020630 FILED AS OF DATE: 20021105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: APPLIED MOLECULAR EVOLUTION INC CENTRAL INDEX KEY: 0001111312 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 330374014 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-31101 FILM NUMBER: 02809446 BUSINESS ADDRESS: STREET 1: 3520 DUNHILL STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 5855974990 MAIL ADDRESS: STREET 1: 3520 DUNHILL STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 10-Q/A 1 a85580a1e10vqza.htm FORM 10-Q AMENDMENT NO. 1 Applied Molecular Evolution, Inc
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q/A
Amendment No. 1

[X]    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly period ended June 30, 2002.

or

[   ]    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _________________ to _________________ .

Commission File No. 000-31101

APPLIED MOLECULAR EVOLUTION, INC.
(Exact name of registrant as specified in its charter)
     
Delaware
  
33-0374014
(State or other jurisdiction of
  
(I.R.S. Employer
incorporation or organization)
  
Identification No.)

3520 Dunhill Street
San Diego, California 92121
(Address of principal executive offices and zip code)

(858) 597-4990
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

YES [X]        NO [   ]

As of June 30, 2002, 22,427,116 shares of the Registrant’s Common Stock were outstanding.

 

EXPLANATORY NOTE
SIGNATURES

Table of Contents

EXPLANATORY NOTE

This Form 10-Q/A Quarterly Report for the period ending June 30, 2002 is being filed to amend the original Form 10-Q Quarterly Report filed August 14, 2002 to correct the number of shares of the Registrant’s Common Stock issued and outstanding as of June 30, 2002. Apart from correcting the number of shares of the Registrant’s Common Stock issued and outstanding, there are no other changes to the Form 10-Q Quarterly Report as originally filed.

In December of 2000, the Registrant repurchased one million two hundred thousand shares of its Common Stock, which now retain the status of treasury stock. The shares of treasury stock were inadvertently included in the number of shares outstanding set forth on the cover pages of the Registrant’s Annual Reports on Form 10-K filed March 19, 2001 and March 5, 2002 as well as its Quarterly Reports on Form 10-Q filed May 1, 2001, August 7, 2001, November 6, 2001, May 7, 2002 and August 14, 2002.

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this amendment to report to be signed on its behalf by the undersigned thereunto duly authorized.
         
Date:  November 5, 2002   By:   /s/ Lawrence E. Bloch, M.D., J.D.
       
        Lawrence E. Bloch, M.D., J.D.
Chief Financial Officer and Secretary

  -----END PRIVACY-ENHANCED MESSAGE-----